ATE199543T1 - Bibphenylamid-derivate als 5-ht1d-antagonisten - Google Patents

Bibphenylamid-derivate als 5-ht1d-antagonisten

Info

Publication number
ATE199543T1
ATE199543T1 AT95929872T AT95929872T ATE199543T1 AT E199543 T1 ATE199543 T1 AT E199543T1 AT 95929872 T AT95929872 T AT 95929872T AT 95929872 T AT95929872 T AT 95929872T AT E199543 T1 ATE199543 T1 AT E199543T1
Authority
AT
Austria
Prior art keywords
6alkyl
independently hydrogen
6alkoxy
pct
hydroxyc1
Prior art date
Application number
AT95929872T
Other languages
English (en)
Inventor
Laramie Mary Gaster
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE199543T1 publication Critical patent/ATE199543T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Lubricants (AREA)
AT95929872T 1994-08-23 1995-08-14 Bibphenylamid-derivate als 5-ht1d-antagonisten ATE199543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416972A GB9416972D0 (en) 1994-08-23 1994-08-23 Carbon side chain/indole/indolene
PCT/EP1995/003226 WO1996006079A1 (en) 1994-08-23 1995-08-14 Biphenylamide derivatives as 5ht1d antagonists

Publications (1)

Publication Number Publication Date
ATE199543T1 true ATE199543T1 (de) 2001-03-15

Family

ID=10760239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929872T ATE199543T1 (de) 1994-08-23 1995-08-14 Bibphenylamid-derivate als 5-ht1d-antagonisten

Country Status (7)

Country Link
US (1) US5817833A (de)
EP (1) EP0777650B1 (de)
JP (1) JPH10504315A (de)
AT (1) ATE199543T1 (de)
DE (1) DE69520279T2 (de)
GB (1) GB9416972D0 (de)
WO (1) WO1996006079A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9421003D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
WO1997007120A1 (en) * 1995-08-11 1997-02-27 Smithkline Beecham Plc Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists
JP2000502051A (ja) * 1995-11-22 2000-02-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht▲下1d▼レセプターアンタゴニストとしての三環系スピロ化合物
GB9707830D0 (en) * 1997-04-18 1997-06-04 Smithkline Beecham Plc Novel compounds
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
US20020049211A1 (en) * 2000-09-06 2002-04-25 Sobolov-Jaynes Susan Beth Combination treatment for depression and anxiety
DE10059418A1 (de) * 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
TW593278B (en) * 2001-01-23 2004-06-21 Wyeth Corp 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
US7271180B2 (en) * 2001-01-23 2007-09-18 Wyeth 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
WO2003068749A1 (en) 2002-02-15 2003-08-21 Glaxo Group Limited Vanilloid receptor modulators
KR102007796B1 (ko) 2013-11-18 2019-08-07 포르마 세라퓨틱스 인크. Bet 브로모도메인 저해제로서 테트라하이드로퀴놀린 조성물
WO2015074081A1 (en) 2013-11-18 2015-05-21 Bair Kenneth W Benzopiperazine compositions as bet bromodomain inhibitors
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470203A (en) * 1964-02-01 1969-09-30 Merck & Co Inc Intermediates for preparing 1-aroylindole-3-alkanoic acids
US3860609A (en) * 1969-05-27 1975-01-14 Novo Terapeutisk Labor As 3-aminoalkyloxyindoles
GB1306230A (de) * 1969-05-27 1973-02-07
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
US5481005A (en) * 1990-07-31 1996-01-02 Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
DE69417427T2 (de) * 1993-09-03 1999-11-25 Smithkline Beecham P.L.C., Brentford Indol- und indolin-derivate als 5ht1d rezeptor antagonisten

Also Published As

Publication number Publication date
DE69520279T2 (de) 2001-10-31
EP0777650B1 (de) 2001-03-07
EP0777650A1 (de) 1997-06-11
US5817833A (en) 1998-10-06
WO1996006079A1 (en) 1996-02-29
GB9416972D0 (en) 1994-10-12
DE69520279D1 (de) 2001-04-12
JPH10504315A (ja) 1998-04-28

Similar Documents

Publication Publication Date Title
ATE199543T1 (de) Bibphenylamid-derivate als 5-ht1d-antagonisten
DE69810958D1 (de) Harnstoffderivate und ihre anwendung als integrin-inhibitoren
AR002011A1 (es) Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.
CO5280079A1 (es) Nuevos compuestos
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
ATE168102T1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
DE69930947D1 (de) Piperazin-4-phenyl-derivate als inhibitoren der wechselwirkung zwischen mdm2 und mdm2
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ATE107636T1 (de) Substituierte phenyl-2-propensäure derivate und ihre verwendung als fungizide.
MXPA04004593A (es) Triazoles fenilo-sustituidos y su uso como inhibidores selectivos de cinasa de tipo activina-5.
NO924783L (no) Terapeutiske midler
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
DE3776044D1 (de) Pyridazinon-derivate.
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ATE229509T1 (de) Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung
HUP9902182A2 (hu) 1,3-Ciklohexándion-származékok alkalmazása szelektív kukorica herbicidként
BG106079A (en) Cyclocarbamate derivatives as progesterone receptor modulators
DE60312511D1 (de) Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika
ECSP982603A (es) Nuevos compuestos heterociclicos
CO4700296A1 (es) Compuestos nuevos para el tratamiento de desordenes del snc y el proceso para su preparacion
TH20305A (th) อนุพันธ์ 3-(5-เททราโซลิล-เบนซิล) อะมิโนพิเพอริดีน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties